| 1672619 |
|
Enliven Therapeutics, Inc. |
0000950170-24-126323 |
2024-11-13 16:10:10 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-24-163507 |
2024-06-18 17:12:01 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0000950170-24-059544 |
2024-05-14 16:10:18 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-24-092522 |
2024-04-11 08:02:54 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-24-090821 |
2024-04-09 16:14:01 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-24-070839 |
2024-03-19 08:46:02 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0000950170-24-031482 |
2024-03-14 16:10:12 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0000950170-23-062042 |
2023-11-09 16:10:11 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0000950170-23-041322 |
2023-08-10 16:10:30 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-23-174006 |
2023-06-23 18:18:30 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-23-173796 |
2023-06-23 16:03:29 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-23-142019 |
2023-05-11 16:11:07 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-23-056303 |
2023-03-01 16:06:55 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-23-044910 |
2023-02-22 16:48:11 |
425
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-23-044902 |
2023-02-22 16:45:03 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-23-036060 |
2023-02-13 17:09:00 |
425
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-23-036052 |
2023-02-13 17:06:08 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-298479 |
2022-12-05 16:33:08 |
425
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-298474 |
2022-12-05 16:31:03 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-282652 |
2022-11-10 16:23:00 |
S-4
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-282630 |
2022-11-10 16:17:45 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-262376 |
2022-10-13 21:06:59 |
425
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-262375 |
2022-10-13 21:04:37 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-262229 |
2022-10-13 16:50:57 |
425
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-262210 |
2022-10-13 16:43:49 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-259683 |
2022-10-07 17:10:02 |
DEFM14A
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-250252 |
2022-09-23 17:04:42 |
PREM14A
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-22-239422 |
2022-09-07 06:49:04 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-22-027108 |
2022-07-29 16:12:14 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-22-022471 |
2022-06-03 16:51:07 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-22-014494 |
2022-04-14 17:00:53 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-22-010212 |
2022-03-15 07:07:13 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-21-055442 |
2021-11-09 07:13:14 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-21-051756 |
2021-10-25 17:12:06 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-21-041896 |
2021-08-06 07:06:47 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-21-214740 |
2021-07-14 09:19:59 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-21-214102 |
2021-07-13 16:07:19 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-21-035335 |
2021-06-30 16:10:26 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-21-032551 |
2021-06-11 07:00:29 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-21-026280 |
2021-05-11 07:09:40 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-21-104184 |
2021-04-01 17:20:51 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-21-011096 |
2021-03-05 07:11:26 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-20-050855 |
2020-11-05 07:09:48 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-20-040169 |
2020-08-14 07:15:23 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001564590-20-022383 |
2020-05-07 07:56:39 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-20-115876 |
2020-04-23 07:15:05 |
8-K
|
| 1672619 |
|
Enliven Therapeutics, Inc. |
0001193125-20-074861 |
2020-03-16 16:06:06 |
8-K
|
